共有 50 笔近期内部人交易记录记录，涉及 Veracyte, Inc. (VCYT), 包括 7 笔买入 和 42 笔卖出. 内部人买入总额为 RSU 奖励 内部人卖出总额为 $11.45M.
近期活跃的重要内部人包括 Haas Kevin Richard, Stapley Marc, Wygant Jonathan. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — VCYT
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-24 |
Haas Kevin Richard |
Officer |
未知 |
- |
- |
- |
- |
| 2026-03-06 |
Stapley Marc |
Chief Executive Officer |
限制性股票授予 (RSU) |
92,099 |
- |
- |
449,653 |
| 2026-03-06 |
Wygant Jonathan |
VP, Chief Accounting Officer |
限制性股票授予 (RSU) |
10,525 |
- |
- |
45,434 |
| 2026-03-06 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
限制性股票授予 (RSU) |
29,603 |
- |
- |
146,949 |
| 2026-03-06 |
Chambers Rebecca |
Chief Financial Officer |
限制性股票授予 (RSU) |
36,181 |
- |
- |
167,377 |
| 2026-03-06 |
Mcguire Annie |
SVP, General Counsel |
限制性股票授予 (RSU) |
32,892 |
- |
- |
127,598 |
| 2026-03-06 |
Leite John |
Chief Commercial Officer-clia |
限制性股票授予 (RSU) |
36,181 |
- |
- |
143,761 |
| 2026-03-04 |
Stapley Marc |
Chief Executive Officer |
知情卖出 |
26,279 |
$36.28 |
$953.37K |
357,554 |
| 2026-03-04 |
Chambers Rebecca |
Chief Financial Officer |
知情卖出 |
13,941 |
$36.33 |
$506.46K |
131,196 |
| 2026-03-04 |
Mcguire Annie |
SVP, General Counsel |
知情卖出 |
1,664 |
$36.34 |
$60.47K |
94,706 |
| 2026-03-04 |
Leite John |
Chief Commercial Officer-clia |
知情卖出 |
5,260 |
$35.19 |
$185.08K |
107,580 |
| 2026-03-02 |
Stapley Marc |
Chief Executive Officer |
RSU 预扣税 |
19,455 |
$36.01 |
$700.57K |
403,077 |
| 2026-03-02 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU 预扣税 |
3,006 |
$36.01 |
$108.25K |
34,909 |
| 2026-03-02 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
知情卖出 |
13,425 |
$36.16 |
$485.43K |
117,346 |
| 2026-03-02 |
Chambers Rebecca |
Chief Financial Officer |
RSU 预扣税 |
7,234 |
$36.01 |
$260.5K |
149,537 |
| 2026-03-02 |
Mcguire Annie |
SVP, General Counsel |
RSU 预扣税 |
6,902 |
$36.01 |
$248.54K |
101,364 |
| 2026-03-02 |
Leite John |
Chief Commercial Officer-clia |
RSU 预扣税 |
7,517 |
$36.01 |
$270.69K |
112,840 |
| 2026-02-26 |
Stapley Marc |
Chief Executive Officer |
RSU 预扣税 |
35,841 |
$38.75 |
$1.39M |
422,532 |
| 2026-02-26 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
RSU 预扣税 |
24,486 |
$38.75 |
$948.83K |
136,806 |
| 2026-02-26 |
Chambers Rebecca |
Chief Financial Officer |
RSU 预扣税 |
12,049 |
$38.75 |
$466.9K |
156,771 |
| 2026-02-26 |
Mcguire Annie |
SVP, General Counsel |
RSU 预扣税 |
10,867 |
$38.75 |
$421.1K |
108,266 |
| 2026-02-26 |
Leite John |
Chief Commercial Officer-clia |
RSU 预扣税 |
8,905 |
$38.75 |
$345.07K |
120,357 |
| 2025-12-16 |
Mcguire Annie |
SVP, General Counsel |
知情卖出 |
100 |
$43.68 |
$4.37K |
67,760 |
| 2025-12-05 |
Eastham Karin |
Director |
期权行权（卖出） |
10,000 |
$7.94 |
$79.4K |
- |
| 2025-12-04 |
Stapley Marc |
Chief Executive Officer |
知情卖出 |
3,220 |
$47.35 |
$152.46K |
318,603 |
| 2025-12-04 |
Chambers Rebecca |
Chief Financial Officer |
知情卖出 |
4,741 |
$47.25 |
$224.01K |
109,496 |
| 2025-12-04 |
Mcguire Annie |
SVP, General Counsel |
知情卖出 |
702 |
$47.51 |
$33.35K |
78,499 |
| 2025-12-04 |
Leite John |
Chief Commercial Officer-clia |
知情卖出 |
1,278 |
$47.51 |
$60.72K |
82,113 |
| 2025-12-02 |
Stapley Marc |
Chief Executive Officer |
RSU 预扣税 |
7,914 |
$46.16 |
$365.31K |
326,271 |
| 2025-12-02 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU 预扣税 |
1,325 |
$46.16 |
$61.16K |
37,420 |
| 2025-12-02 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
RSU 预扣税 |
2,955 |
$46.16 |
$136.4K |
89,486 |
| 2025-12-02 |
Chambers Rebecca |
Chief Financial Officer |
RSU 预扣税 |
3,384 |
$46.16 |
$156.21K |
122,774 |
| 2025-12-02 |
Mcguire Annie |
SVP, General Counsel |
RSU 预扣税 |
3,052 |
$46.16 |
$140.88K |
79,921 |
| 2025-12-02 |
Leite John |
Chief Commercial Officer-clia |
RSU 预扣税 |
2,900 |
$46.16 |
$133.86K |
83,391 |
| 2025-11-25 |
Jones Evan/ Fa |
Director |
知情卖出 |
1,106 |
$50.25 |
$55.58K |
29,362 |
| 2025-11-25 |
Leite John |
Chief Commercial Officer-clia |
知情卖出 |
2,808 |
$50.00 |
$140.4K |
86,291 |
| 2025-11-20 |
Holstein Jens |
Director |
知情卖出 |
1,460 |
$43.21 |
$63.09K |
27,199 |
| 2025-11-10 |
Wygant Jonathan |
VP, Chief Accounting Officer |
知情卖出 |
5,102 |
$42.33 |
$215.98K |
38,745 |
| 2025-11-07 |
Wygant Jonathan |
VP, Chief Accounting Officer |
知情卖出 |
5,818 |
$40.21 |
$233.93K |
43,847 |
| 2025-11-05 |
Jones Evan/ Fa |
Director |
期权行权（卖出） |
10,000 |
$5.28 |
$52.8K |
- |
| 2025-11-05 |
Eastham Karin |
Director |
知情卖出 |
9,674 |
$40.02 |
$387.19K |
13,554 |
| 2025-11-05 |
Chambers Rebecca |
Chief Financial Officer |
知情卖出 |
7,000 |
$41.00 |
$287K |
126,158 |
| 2025-11-05 |
Mcguire Annie |
SVP, General Counsel |
知情卖出 |
6,466 |
$40.00 |
$258.64K |
82,973 |
| 2025-10-28 |
Wygant Jonathan |
VP, Chief Accounting Officer |
限制性股票授予 (RSU) |
2,886 |
- |
- |
49,665 |
| 2025-10-06 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
知情卖出 |
8,349 |
$36.02 |
$300.71K |
92,441 |
| 2025-10-01 |
Epstein Robert S |
Director |
期权行权（卖出） |
10,000 |
$7.94 |
$79.4K |
- |
| 2025-10-01 |
Mcguire Annie |
SVP, General Counsel |
知情卖出 |
2,160 |
$35.00 |
$75.61K |
89,439 |
| 2025-10-01 |
Leite John |
Chief Commercial Officer-clia |
知情卖出 |
2,539 |
$35.00 |
$88.87K |
89,099 |
| 2025-09-19 |
Mcguire Annie |
SVP, General Counsel |
知情卖出 |
2,283 |
$33.69 |
$76.92K |
91,599 |
| 2025-09-04 |
Stapley Marc |
Chief Executive Officer |
知情卖出 |
7,667 |
$30.41 |
$233.13K |
334,185 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
